Abbott Laboratories

AbbVie (NYSE: ABBV), one of the world’s largest pharmaceutical companies, is usually considered a blue chip dividend stock…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…

Quick Read Abbott (ABT) is down 23% year to date with insiders buying near $92; Pfizer (PFE) pairs…

We do not have enough money coming into this market. The funds flow only to stocks tied to…

Economic downturns cast a wide net across the market, and there’s no stock that’s completely immune to a…

Traders work on the floor of the New York Stock Exchange. NYSE U.S. stock futures were little changed…

MADISON, Wis. — Abbott expects to close its acquisition of Exact Sciences on Monday, the healthcare giant said.…

It might not seem like it, but the S&P 500 flirted with bear market territory earlier this year.…

America’s workforce is on the verge of an unprecedented transformation. More Americans are turning 65 in 2025 than…

Last week started with the big banks delivering strong earnings and ended with regional lenders writing off bad…

Shares of Abbott Laboratories fell 3% on Wednesday after the diversified health-care company delivered another less-than-stellar quarter. Revenue…

AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now?